Holocene Advisors’s Terns Pharmaceuticals TERN Stock Holding History

Holocene Advisors’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-4,115,828	Closed	-$217M	–	998
2026 Q1	$217M	Buy	4,115,828 +1,340,335	+48%	+$55.1M	0.52%	48
2025 Q4	$112M	Buy	+2,775,493	New	+$64.1M	0.24%	117

Other funds holding TERN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Holocene Advisors's TERN Position: Q2 2026 in Review

Holocene Advisors sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 4,115,828 shares — an estimated $217M sold.

Holocene Advisors first reported a position in TERN in Q4 2025 and held it in 2 quarters. The position peaked at $217M in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

Holocene Advisors reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Holocene Advisors sold 4,115,828 Terns Pharmaceuticals shares in Q2 2026, an estimated $217M.
Holocene Advisors first reported a position in Terns Pharmaceuticals in Q4 2025 and held it in 2 quarters.
Holocene Advisors's Terns Pharmaceuticals position peaked at $217M in Q1 2026.
1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Holocene Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.